ClinicalTrials.gg
RecruitingNCT05906810Updated May 21, 2025

Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Peri-implantitis and Peri-implant Mucositis

An interventional study of Non-surgical periodontal treatment in Atherosclerosis, Endothelial Dysfunction and Peri-Implantitis, sponsored by University of Catania. Recruiting at 1 site in Italy. Per ClinicalTrials.gov, last updated 2025-05-21.

Sponsored by University of Catania · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as recruiting.
  • Registered 2 years 8 months after the study started (first participant enrolled Oct 2020, registered Jun 2023).
  • Started Oct 2020; still recruiting 6 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 81 studies in Atherosclerosis with a site in Italy — 12 open to participants now, 22 under way, 10 of them phase 3. Atherosclerosis · Italy.

Planned enrollment
37th of 51
90 · median 423
Started
2020
with 6 others
No phase
20 of 81
4 open now
Primary completion
2025-11
later than 4 of 21 live
Registered
63rd of 81
by date

Among the 81 studies in Atherosclerosis with a site in Italy, this one is the 37th largest by planned enrollment of the 51 interventional ones that give a count, is one of 7 that started in 2020, is one of 20 with no phase, reaches primary completion later than 4 of the 21 other live ones, and was the 63rd registered.

Atherosclerosis

1,519 studies on the registry are indexed under Atherosclerosis; 226 are open to participants now.

Browse Atherosclerosis studies →

Open to participants now

12 of the 81 studies in Atherosclerosis with a site in Italy are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 164 Atherosclerosis studies recruiting now, 86 (52%) set no upper age limit and 34 (21%) stop at 75 or younger; 16 take children under 18; 35 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Atherosclerosis with a site in Italy, or all of them as a file.
02

Study summary

A double-blind randomized-controlled clinical trial is conducted in order to evaluate the impact of non-surgical periodontal treatment on endothelial dysfunction parameters in subjects with peri-implantitis/peri-implant mucositis and without any cardiovascular disease.

Read the detailed description

A double-blind randomized-controlled clinical trial is conducted in order to evaluate the impact of non-surgical periodontal treatment on endothelial dysfunction parameters in subjects with peri-implantitis/peri-implant mucositis and without any cardiovascular disease.

90 patients: 30 with peri-implantitis, 30 with peri-implant mucositis and 30 healthy controls and without periodontitis history.

All the patients are assessed for clinical, periodontal, blood and non-invasive ultrasound cardiovascular parameters. Measurements are taken before and after initial periodontal treatment in the peri-implantitis/peri-implant mucositis subjects.

03

Conditions studied

  • Atherosclerosis
  • Endothelial Dysfunction
  • Peri-Implantitis
  • Peri-implant Mucositis
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

PERI-IMPLANTITIS GROUP

Inclusion Criteria:

  • Clinically diagnosed with peri-implantitis according to the EFP/AAP 2017 criteria.

Exclusion Criteria:

  • Periodontal treatment, implant surgery, antibiotics, NSAIDs, during the last 6 months.
  • Pregnancy.
  • Cardiovascular Diseases.

PERI-IMPLANT MUCOSITIS GROUP

Inclusion Criteria:

  • Clinically diagnosed with peri-implant mucositis according to the EFP/AAP 2017 criteria.

Exclusion Criteria:

  • Periodontal treatment, implant surgery, antibiotics, NSAIDs, immunosuppressants during the last 6 months.
  • Pregnancy.
  • Cardiovascular Diseases.

HEALTHY GROUP

Inclusion Criteria:

  • Clinically diagnosed with healthy periodontum withouth periodontitis history according to the EFP/AAP 2017 criteria.

Exclusion Criteria:

  • Scaling, antibiotics, NSAIDs, immunosuppressants during the last 6 months.
  • Pregnancy.
  • Cardiovascular Diseases.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Peri-implantitis

    Subjects diagnosed with peri-implantitis according to the most recent international guidelines and without cardiovascular diseases.

    Procedure: Non-surgical periodontal treatment

  • Active comparator
    Peri-implant mucositis

    Subjects diagnosed with peri-implant mucositis according to the most recent international guidelines and without cardiovascular diseases.

    Procedure: Non-surgical periodontal treatment

  • No intervention
    Healthy

    Subjects without periodontitis and with good gingival health.

Interventions

  • ProcedureNon-surgical periodontal treatment

    Subgingival biofilm ultrasonic debridement

06

What researchers measure

Primary outcomes

  1. Pulse Wave Velocity carotid-femoral (PWV-CF)

    The speed of pulse wave propagation between carotid-femoral sites

    Time frame: 8 weeks

  2. Pulse Wave Velocity carotid-femoral (PWV-CR)

    The speed of pulse wave propagation between carotid-radial sites

    Time frame: 8 weeks

  3. Carotid Intima-Media Thickness (CIMT)

    The thickness of the carotid intima and media

    Time frame: 8 weeks

  4. Distensibility Coefficient (DC)

    The relative change in luminal area during systole for a given pressure change (pulsed pressure), will be calculated assuming the lumen to be circular.

    Time frame: 8 weeks

  5. Advanced Glycation End products (AGEs)

    A group of endogenous heterogeneous compounds that are constantly formed under physiological conditions with prooxidant and cytotoxic properties. Measurements are performed by fluorescence spectroscopy technique.

    Time frame: 8 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2020 (actual). Primary completion is estimated for Nov 2025, 61 months after the start.

Of 178 non-industry interventional studies with no phase under Atherosclerosis, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 56. This study's planned 61 months is above that.

Counting every sponsor, half of 198 studies reached it within 30 months; a quarter within 17 and three quarters within 56.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 7, 2023
First posted
Jun 18, 2023
StartActual
Oct 5, 2020
Primary completionEst.
Nov 20, 2025
CompletionEst.
Dec 20, 2025
Last update
May 21, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05906810
Lead sponsor
University of Catania
Responsible party
Gaetano Isola (Researcher, University of Catania) — Principal investigator
First posted
Jun 18, 2023
Start date
Oct 5, 2020
Primary completion
Nov 20, 2025 (estimated)
Completion
Dec 20, 2025 (estimated)
Last update
May 21, 2025

Study contacts

Gaetano Isola, PhD
Contact
gaetano.isola@unict.it
+39-095-378-2453 ext. CT

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion